Genetic risk for Huntington Disease and reproductive decision-making: A systematic review

Clin Genet. 2023 Aug;104(2):147-162. doi: 10.1111/cge.14345. Epub 2023 Apr 24.

Abstract

Huntington Disease (HD) is an incurable autosomal dominant single gene neurodegenerative disorder. Typical onset is between 30 and 40 years and characterised by motor difficulties, cognitive impairment, and behavioural and personality changes. The availability of reproductive testing means that affected and at-risk individuals can make reproductive decisions with genetic risk in mind. We aimed to summarise the literature on reproductive decision-making in the context of HD risk in terms of outcomes and the subjective experiences of at-risk individuals. Five databases were searched. Findings were synthesised using Framework analysis to identify common factors across results of quantitative and qualitative studies. Twenty five studies met inclusion criteria. Framework analysis identified the following key areas: 'The relationship between reproductive intentions and HD genetic risk', 'Views on assistive options', 'Complexity and challenges in reproductive decision-making', 'Actual reproductive outcomes', and 'Other factors influencing reproductive decision-making'. Quality of included studies was mixed. Reproductive decision making in the context of HD risk was found to be a complex and emotionally challenging process. Further research is required into reproductive decision-making and outcomes among those not utilising assistive options, and in developing a model of reproductive decision-making in HD.

Keywords: Huntington Disease; genetic risk; inherited condition; reproductive decision making.

Publication types

  • Systematic Review
  • Review

MeSH terms

  • Decision Making
  • Humans
  • Huntington Disease* / genetics
  • Reproduction / genetics
  • Risk Factors